Zach Haigney is the author of The Trip Report, a newsIetter that covers the emerging psychedelic science, medicine, and policy landscape. In this conversation, Zach and Brom discuss emerging trends, questions and hot topics in the psychedelics industry including:
- The lines of tension between Drug Development and Drug Policy
- Directive vs Non-Directive Psychedelic Therapy
- How Psychedelics are inverting the traditional drug development model
- What business models will emerge in psychedelics?
- Are fears about VC investment in psychedelics overstated?
- How psychedelics can be thought of as a form of hormetic therapy
- What can psychedelics be used for outside of treating mental health issues?
